NCT00408694 2018-01-30
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
1 trialsCompleted × Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 × Bevacizumab × Clear all